News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

e-Therapeutics plc Outlines Goals for 2012 and Announces Presentation at Biotech Showcase Conference


1/9/2012 7:08:04 AM

OXFORD & NEWCASTLE, England--(BUSINESS WIRE)--Drug discovery and development company e-Therapeutics plc (AIM: ETX) today provides an update on its goals and expectations for 2012.

•Four drugs to enter clinical trials ?ETS2101 (anti-cancer drug; phase I programme starting in Q1) ?ETX1153c (phase I trial for C. difficile infection starting in Q2)

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES